Inflammatix
AI/Machine Learning
About Inflammatix
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.
Target Market
Healthcare
Product and Services
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.
Founders
Leadership Team
Investors
Awards
Fundings
| Stage |
Amount |
Date |
| Series D |
$102M |
2021 |
Valuations
